— Know what they know.
Not Investment Advice

TMDX NASDAQ

TransMedics Group, Inc.
1W: +11.0% 1M: -40.0% 3M: -48.7% YTD: -43.9% 1Y: -44.8% 3Y: -8.0% 5Y: +209.6%
$68.94
+0.09 (+0.12%)
 
Weekly Expected Move ±12.5%
$47 $55 $63 $71 $79
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 31 · $2.4B mcap · 33M float · 3.85% daily turnover · Short 67% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
50.8 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 40.0%  ·  5Y Avg: 17.0%
Cost Advantage
61
Intangibles
34
Switching Cost
47
Network Effect
67
Scale
55
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TMDX shows a Weak competitive edge (50.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. ROIC of 40.0% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$85
Low
$122
Avg Target
$142
High
Based on 5 analysts since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 9Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$123.50
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-06 Needham $166 $142 -24 +92.3% $73.84
2026-05-06 Canaccord Genuity William Plovanic $148 $124 -24 +30.6% $94.93
2026-05-06 Piper Sandler $140 $120 -20 +26.4% $94.93
2026-05-06 Stifel Nicolaus Thomas Stephan $130 $85 -45 -10.5% $94.93
2026-05-06 Robert W. Baird David Rescott $120 $140 +20 +47.5% $94.93
2026-03-09 Stifel Nicolaus Initiated $130 -3.5% $134.77
2025-12-17 Canaccord Genuity $147 $148 +1 +18.4% $125.04
2025-12-08 Needham $148 $166 +18 +21.6% $136.51
2025-12-02 Morgan Stanley $145 $135 -10 -10.3% $150.42
2025-10-30 Piper Sandler Matt O'Brien $90 $140 +50 +4.2% $134.32
2025-10-30 Canaccord Genuity Jason Mills $109 $147 +38 +9.4% $134.32
2025-10-23 Needham $109 $148 +39 +23.8% $119.54
2025-10-13 Jefferies Initiated $145 +35.1% $107.29
2025-10-07 Evercore ISI Initiated $155 +36.0% $113.93
2024-12-11 Robert W. Baird David Rescott $150 $120 -30 +78.1% $67.36
2024-12-11 Piper Sandler Matt O'Brien $180 $90 -90 +33.6% $67.36
2024-10-29 Robert W. Baird Joe Vruwink $200 $150 -50 +69.1% $88.70
2024-10-29 Canaccord Genuity Jason Mills $169 $109 -60 -13.7% $126.24
2024-10-29 Needham Mike Matson $208 $109 -99 -13.7% $126.24
2024-10-29 Oppenheimer Suraj Kalia $200 $125 -75 -1.0% $126.24
2024-09-23 Robert W. Baird David Rescott Initiated $200 +25.4% $159.50
2024-09-04 Piper Sandler Matt O'Brien $170 $180 +10 +13.6% $158.42
2024-08-21 Needham Mike Matson Initiated $208 +25.2% $166.18
2024-08-01 Canaccord Genuity William Plovanic Initiated $169 +3.0% $164.02
2024-08-01 Oppenheimer Suraj Kalia $45 $200 +155 +40.6% $142.26
2024-07-15 Morgan Stanley Patrick Wood $63 $145 +82 +2.0% $142.19
2024-07-15 Piper Sandler Matt O'Brien Initiated $170 +19.6% $142.19
2024-06-03 Stephens George Sellers Initiated $151 +13.0% $133.63
2023-01-06 Morgan Stanley $37 $63 +26 +10.5% $57.02
2022-08-03 Morgan Stanley $34 $37 +3 -4.2% $38.63
2022-08-02 Oppenheimer Initiated $45 +18.5% $37.99
2022-07-26 Cowen & Co. $39 $45 +6 +27.9% $35.18
2022-06-29 Morgan Stanley $25 $34 +9 +6.4% $31.96
2022-06-28 Cowen & Co. Initiated $39 +15.5% $33.78
2022-05-04 Morgan Stanley Initiated $25 -18.4% $30.62

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
May 22, 2026
DCF
1
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TMDX receives an overall rating of B-. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: DCF (1/5), D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-11 B B-
2026-04-01 B- B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

74 Grade A
Profitability
64
Balance Sheet
75
Earnings Quality
76
Growth
81
Value
47
Momentum
100
Safety
100
Cash Flow
64
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TMDX scores highest in Safety (100/100) and lowest in Value (47/100). An overall grade of A places TMDX among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.80
Safe Zone
Piotroski F-Score
7/9
Beneish M-Score
-1.03
Possible Manipulator
Ohlson O-Score
-8.49
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 81.9/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 1.28x
Accruals: -5.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TMDX scores 4.80, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TMDX scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TMDX's score of -1.03 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TMDX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TMDX receives an estimated rating of AA- (score: 81.9/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). TMDX's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
13.72x
PEG
0.06x
P/S
3.73x
P/B
4.78x
P/FCF
23.77x
P/OCF
16.34x
EV/EBITDA
26.06x
EV/Revenue
5.63x
EV/EBIT
34.26x
EV/FCF
23.65x
Earnings Yield
4.78%
FCF Yield
4.21%
Shareholder Yield
0.00%
Graham Number
$37.38
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 13.7x earnings, TMDX trades at a reasonable valuation. Graham's intrinsic value formula yields $37.38 per share, 84% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.925
NI / EBT
×
Interest Burden
0.855
EBT / EBIT
×
EBIT Margin
0.164
EBIT / Rev
×
Asset Turnover
0.679
Rev / Assets
×
Equity Multiplier
2.668
Assets / Equity
=
ROE
49.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TMDX's ROE of 49.0% is driven by Asset Turnover (0.679), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.92 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
287.33%
Fair P/E
583.16x
Intrinsic Value
$2770.05
Price/Value
0.04x
Margin of Safety
96.41%
Premium
-96.41%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with TMDX's realized 287.3% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $2770.05, TMDX appears undervalued with a 96% margin of safety. The adjusted fair P/E of 583.2x compares to the current market P/E of 13.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1775 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$68.94
Median 1Y
$63.41
5th Pctile
$21.52
95th Pctile
$190.48
Ann. Volatility
70.1%
Analyst Target
$123.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Waleed H. Hassanein,
M.D. President and Chief Executive Officer
$776,923 $4,364,013 $10,915,533
Tamer Khayal, M.D.
Former Chief Commercial Officer
$496,316 $1,357,775 $3,750,144
Nicholas Corcoran Supply
Vice President of Supply Chain and Operations
$451,731 $977,573 $2,819,576
Gerardo Hernandez Financial
ancial Officer
$488,462 $271,540 $1,570,572
Anil Ranganath President,
ior Vice President, General Counsel and Corporate Secretary
$412,308 $434,494 $1,503,075

CEO Pay Ratio

53:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,915,533
Avg Employee Cost (SGA/emp): $206,200
Employees: 898

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
898
+23.4% YoY
Revenue / Employee
$674,269
Rev: $605,494,000
Profit / Employee
$211,905
NI: $190,291,000
SGA / Employee
$206,200
Avg labor cost proxy
R&D / Employee
$76,899
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -37.8% -47.8% -51.5% -54.6% -55.6% -49.1% -28.4% -22.2% -13.9% -28.0% -15.4% -6.3% 1.8% 20.1% 19.4% 26.8% 39.2% 50.2% 54.2% 49.0% 49.00%
ROA -23.3% -29.4% -30.8% -32.7% -33.3% -29.4% -17.6% -13.7% -8.6% -17.4% -5.1% -2.1% 0.6% 6.6% 4.7% 6.5% 9.5% 12.2% 20.3% 18.4% 18.36%
ROIC -1.6% -2.1% -1.6% -1.7% -1.7% -1.5% -46.2% -35.5% -22.5% -56.0% -8.8% -4.3% -0.6% 12.2% 9.1% 12.5% 18.1% 23.1% 42.3% 40.0% 40.00%
ROCE -18.6% -24.2% -36.1% -38.5% -39.2% -34.4% -12.8% -9.6% -4.9% -11.5% -2.4% -0.3% 1.4% 5.6% 5.3% 7.7% 11.3% 14.4% 12.4% 10.7% 10.67%
Gross Margin 68.4% 70.3% 72.3% 76.2% 69.9% 70.5% 66.0% 69.2% 70.0% 61.2% 59.0% 61.8% 60.5% 55.9% 59.2% 61.5% 61.4% 58.8% 58.1% 58.2% 58.16%
Operating Margin -1.2% -2.2% -1.2% -59.0% -47.5% -21.6% -21.6% -5.0% -1.7% -42.7% 3.2% 12.8% 10.9% 3.6% 7.1% 19.1% 23.2% 16.2% 13.2% 7.6% 7.64%
Net Margin -1.3% -2.4% -1.3% -66.5% -56.2% -28.9% -21.4% -6.3% -1.9% -38.3% 5.0% 12.6% 10.7% 3.9% 5.6% 17.9% 22.2% 16.9% 65.6% 4.2% 4.21%
EBITDA Margin -1.1% -2.1% -1.1% -56.1% -47.4% -21.6% -13.5% -0.1% 6.0% -32.3% 13.8% 17.4% 15.0% 12.0% 13.4% 25.3% 29.5% 23.2% 20.2% 14.5% 14.47%
FCF Margin -89.3% -1.1% -1.1% -1.2% -1.0% -84.7% -61.8% -39.4% -27.0% -72.0% -68.2% -68.3% -54.0% -30.0% -18.3% -13.0% 3.3% 21.3% 22.1% 23.8% 23.80%
OCF Margin -88.2% -1.0% -95.4% -1.0% -84.6% -67.5% -49.0% -30.3% -21.7% -13.2% -5.4% -2.6% 6.6% 9.3% 11.1% 10.1% 21.7% 31.4% 31.8% 34.6% 34.63%
ROE 3Y Avg snapshot only 16.77%
ROE 5Y Avg snapshot only -6.77%
ROA 3Y Avg snapshot only 6.91%
ROIC Economic snapshot only 19.54%
Cash ROA snapshot only 20.61%
Cash ROIC snapshot only 48.46%
CROIC snapshot only 33.31%
NOPAT Margin snapshot only 28.58%
Pretax Margin snapshot only 14.05%
R&D / Revenue snapshot only 12.07%
SGA / Revenue snapshot only 32.16%
SBC / Revenue snapshot only 5.95%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -30.56 -24.21 -12.03 -16.07 -18.44 -29.92 -54.53 -86.31 -153.70 -49.91 -107.79 -251.51 1771.71 171.65 61.91 54.86 75.85 49.82 26.16 20.93 13.724
P/S Ratio 30.61 32.48 17.58 19.26 17.11 17.59 21.14 20.51 18.09 9.31 11.17 8.64 14.82 13.97 4.97 5.50 10.23 8.07 8.22 5.66 3.730
P/B Ratio 8.82 8.82 7.84 11.10 12.97 18.60 10.54 13.04 14.59 9.53 19.66 18.69 38.74 40.83 9.60 11.75 23.78 20.00 10.52 7.61 4.776
P/FCF -34.26 -30.87 -16.43 -16.59 -16.62 -20.77 -34.23 -52.03 -67.02 -12.92 -16.36 -12.64 -27.43 -46.49 -27.12 -42.47 313.24 37.90 37.27 23.77 23.772
P/OCF 224.09 149.62 44.99 54.38 47.15 25.69 25.82 16.34 16.338
EV/EBITDA -33.87 -25.66 -12.84 -17.58 -20.51 -35.09 -64.82 -118.05 -389.15 -73.17 -392.60 276.86 229.79 98.44 37.61 34.68 50.18 35.94 33.40 26.06 26.055
EV/Revenue 27.57 29.26 15.98 18.02 16.16 16.91 19.71 19.39 17.21 8.61 11.67 9.04 15.15 14.27 5.38 5.87 10.57 8.39 8.19 5.63 5.629
EV/EBIT -31.63 -24.31 -11.99 -16.40 -18.99 -31.58 -56.79 -94.74 -210.95 -56.88 -177.51 -1394.96 600.16 157.59 60.31 50.19 66.65 44.48 40.89 34.26 34.264
EV/FCF -30.86 -27.80 -14.93 -15.52 -15.70 -19.97 -31.91 -49.19 -63.74 -11.96 -17.10 -13.23 -28.06 -47.49 -29.37 -45.35 323.71 39.40 37.13 23.65 23.648
Earnings Yield -3.3% -4.1% -8.3% -6.2% -5.4% -3.3% -1.8% -1.2% -0.7% -2.0% -0.9% -0.4% 0.1% 0.6% 1.6% 1.8% 1.3% 2.0% 3.8% 4.8% 4.78%
FCF Yield -2.9% -3.2% -6.1% -6.0% -6.0% -4.8% -2.9% -1.9% -1.5% -7.7% -6.1% -7.9% -3.6% -2.2% -3.7% -2.4% 0.3% 2.6% 2.7% 4.2% 4.21%
PEG Ratio snapshot only 0.056
Price/Tangible Book snapshot only 7.829
EV/OCF snapshot only 16.253
EV/Gross Profit snapshot only 9.526
Acquirers Multiple snapshot only 37.902
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $37.38
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 12.36 12.36 5.11 5.11 5.11 5.11 10.66 10.66 10.66 10.66 9.30 9.30 9.30 9.30 8.30 8.30 8.30 8.30 7.14 7.14 7.142
Quick Ratio 11.35 11.35 4.47 4.47 4.47 4.47 9.79 9.79 9.79 9.79 8.49 8.49 8.49 8.49 7.52 7.52 7.52 7.52 6.59 6.59 6.594
Debt/Equity 0.33 0.33 0.65 0.65 0.65 0.65 0.36 0.36 0.36 0.36 3.76 3.76 3.76 3.76 2.27 2.27 2.27 2.27 0.99 0.99 0.993
Net Debt/Equity -0.88 -0.88 -0.72 -0.72 -0.72 -0.72 -0.71 -0.71 -0.71 -0.71 0.88 0.88 0.88 0.88 0.79 0.79 0.79 0.79 -0.04 -0.04 -0.039
Debt/Assets 0.23 0.23 0.32 0.32 0.32 0.32 0.24 0.24 0.24 0.24 0.73 0.73 0.73 0.73 0.64 0.64 0.64 0.64 0.44 0.44 0.440
Debt/EBITDA -1.42 -1.08 -1.16 -1.09 -1.08 -1.27 -2.38 -3.45 -10.11 -2.99 -71.86 53.20 21.81 8.87 8.20 6.27 4.63 3.92 3.16 3.42 3.419
Net Debt/EBITDA 3.73 2.83 1.29 1.21 1.20 1.41 4.70 6.83 20.00 5.92 -16.87 12.49 5.12 2.08 2.87 2.20 1.62 1.37 -0.13 -0.14 -0.136
Interest Coverage -6.76 -8.78 -10.40 -11.06 -11.55 -10.68 -8.95 -6.49 -2.29 -3.54 -1.47 -0.14 0.63 2.51 2.74 4.00 5.97 7.63 8.80 5.97 5.972
Equity Multiplier 1.46 1.46 1.99 1.99 1.99 1.99 1.48 1.48 1.48 1.48 5.15 5.15 5.15 5.15 3.52 3.52 3.52 3.52 2.26 2.26 2.258
Cash Ratio snapshot only 5.469
Debt Service Coverage snapshot only 7.854
Cash to Debt snapshot only 1.040
FCF to Debt snapshot only 0.322
Defensive Interval snapshot only 743.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.23 0.22 0.21 0.27 0.36 0.50 0.45 0.58 0.73 0.93 0.49 0.60 0.73 0.82 0.58 0.65 0.70 0.75 0.65 0.68 0.679
Inventory Turnover 0.84 0.80 0.68 0.79 1.06 1.51 1.59 2.10 2.64 3.66 2.70 3.45 4.35 5.04 3.96 4.36 4.71 4.96 5.09 5.45 5.452
Receivables Turnover 4.46 4.20 4.73 6.11 8.04 11.21 5.57 7.10 9.01 11.44 5.30 6.51 7.87 8.80 5.47 6.05 6.59 7.02 6.65 6.99 6.988
Payables Turnover 2.29 2.18 2.32 2.71 3.62 5.14 5.64 7.45 9.36 13.00 10.90 13.92 17.58 20.34 15.62 17.21 18.57 19.55 23.51 25.21 25.206
DSO 82 87 77 60 45 33 66 51 41 32 69 56 46 41 67 60 55 52 55 52 52.2 days
DIO 437 458 537 460 344 242 230 174 138 100 135 106 84 72 92 84 78 74 72 67 66.9 days
DPO 159 167 158 135 101 71 65 49 39 28 33 26 21 18 23 21 20 19 16 14 14.5 days
Cash Conversion Cycle 359 378 457 385 288 204 230 176 140 103 171 136 109 96 136 123 113 107 111 105 104.7 days
Fixed Asset Turnover snapshot only 1.911
Operating Cycle snapshot only 119.2 days
Cash Velocity snapshot only 1.302
Capital Intensity snapshot only 1.680
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 23.8% 17.3% 18.0% 55.3% 71.8% 1.5% 2.1% 2.0% 1.9% 1.7% 1.6% 1.5% 1.4% 1.1% 82.7% 64.4% 48.1% 41.2% 37.1% 30.2% 30.24%
Net Income 13.9% -19.8% -53.8% -68.5% -59.1% -11.4% 18.1% 39.6% 62.7% 15.2% 30.9% 64.0% 1.2% 1.9% 2.4% 5.8% 22.9% 1.8% 4.4% 2.5% 2.51%
EPS 27.2% -17.4% -50.4% -65.0% -57.1% -2.1% 28.9% 47.7% 68.0% 21.4% 35.3% 66.5% 1.2% 1.8% 2.4% 5.2% 19.8% 1.5% 3.6% 2.9% 2.87%
FCF 10.8% 3.7% -5.4% -53.3% -98.0% -1.0% -78.3% -3.4% 23.0% -1.3% -1.9% -3.3% -3.8% 12.8% 50.9% 68.8% 1.1% 2.0% 2.7% 3.4% 3.39%
EBITDA 16.4% -23.8% -62.6% -80.1% -66.4% -7.4% 24.5% 51.2% 83.5% 34.7% 74.7% 1.5% 4.5% 3.6% 9.8% 7.5% 3.7% 1.3% 1.3% 66.2% 66.19%
Op. Income 15.5% -16.5% -49.4% -70.0% -56.9% -5.9% 20.3% 42.9% 63.7% -5.9% 8.6% 41.1% 94.8% 1.8% 2.3% 4.7% 96.4% 2.1% 1.9% 79.8% 79.82%
OCF Growth snapshot only 3.46%
Asset Growth snapshot only 32.87%
Equity Growth snapshot only 1.07%
Debt Growth snapshot only -9.38%
Shares Change snapshot only -9.32%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.1% 77.3% 70.3% 65.1% 84.2% 99.7% 1.1% 1.3% 1.3% 1.4% 1.4% 1.3% 1.2% 99.1% 86.4% 74.8% 74.76%
Revenue 5Y 1.3% 98.9% 87.7% 79.1% 85.5% 88.1% 88.2% 90.8% 90.78%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 1.2% 89.7% 79.5% 71.8% 92.1% 1.0% 1.1% 1.2% 1.2% 1.3% 1.3% 1.2% 1.0% 87.8% 77.1% 66.1% 66.14%
Gross Profit 5Y 1.3% 99.4% 87.5% 78.2% 84.8% 85.5% 85.2% 86.7% 86.65%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 47.4% 47.4% 38.1% 38.1% 38.1% 38.1% 66.8% 66.8% 66.8% 66.8% 81.3% 81.3% 81.3% 81.3% 56.8% 56.8% 56.80%
Assets 5Y 75.7% 75.7% 50.2% 50.2% 50.2% 50.2% 47.7% 47.7% 47.69%
Equity 3Y 50.8% 50.8% 50.8% 50.8% 9.7% 9.7% 9.7% 9.7% 49.9% 49.9% 49.9% 49.9% 36.2% 36.2% 36.17%
Book Value 3Y 31.4% 31.1% 35.0% 41.9% 1.6% 1.4% 1.1% 0.8% 38.5% 33.1% 32.5% 35.7% 25.5% 31.0% 31.05%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.92 0.93 0.99 0.67 0.96 0.82 0.73 0.70 0.77 0.81 0.83 0.86 0.71 0.74 0.77 0.79 0.83 0.87 0.90 0.93 0.933
Earnings Stability 0.58 0.95 0.84 0.35 0.80 0.93 0.51 0.00 0.10 0.62 0.01 0.35 0.08 0.20 0.38 0.59 0.67 0.67 0.63 0.72 0.717
Margin Stability 0.93 0.93 0.92 0.91 0.90 0.92 0.93 0.93 0.93 0.95 0.95 0.93 0.91 0.91 0.92 0.91 0.91 0.92 0.93 0.93 0.934
Rev. Growth Consistency 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.94 0.92 0.50 0.50 0.50 0.95 0.93 0.84 0.50 0.94 0.88 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.00 0.05 0.00 0.00 0.000
ROE Trend -0.27 -0.23 -0.24 -0.15 0.27 0.33 0.40 0.30 0.24 0.35 0.42 0.64 0.34 0.33 0.35 0.38 0.42 0.29 0.293
Gross Margin Trend 0.08 0.06 0.08 0.09 0.08 0.06 0.02 -0.01 -0.01 -0.03 -0.06 -0.08 -0.10 -0.10 -0.07 -0.06 -0.05 -0.02 -0.02 -0.02 -0.018
FCF Margin Trend 0.81 0.28 0.19 0.06 0.04 0.32 0.52 0.78 0.69 0.23 0.16 0.09 0.11 0.48 0.47 0.41 0.44 0.72 0.65 0.64 0.644
Sustainable Growth Rate 1.8% 20.1% 19.4% 26.8% 39.2% 50.2% 54.2% 49.0% 49.00%
Internal Growth Rate 0.6% 7.1% 4.9% 6.9% 10.5% 13.8% 25.5% 22.5% 22.49%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.88 0.78 0.65 0.85 0.91 1.15 1.26 1.27 1.84 0.71 0.52 0.77 7.91 1.15 1.38 1.01 1.61 1.94 1.01 1.28 1.281
FCF/OCF 1.01 1.01 1.12 1.14 1.22 1.25 1.26 1.30 1.24 5.45 12.66 26.01 -8.17 -3.22 -1.66 -1.28 0.15 0.68 0.69 0.69 0.687
FCF/Net Income snapshot only 0.880
OCF/EBITDA snapshot only 1.603
CapEx/Revenue 1.1% 1.2% 11.6% 13.9% 18.4% 17.2% 12.7% 9.1% 5.3% 58.8% 62.8% 65.7% 60.6% 39.4% 29.4% 23.1% 18.4% 10.1% 9.8% 10.8% 10.83%
CapEx/Depreciation snapshot only 2.093
Accruals Ratio -0.03 -0.07 -0.11 -0.05 -0.03 0.04 0.05 0.04 0.07 -0.05 -0.02 -0.00 -0.04 -0.01 -0.02 -0.00 -0.06 -0.11 -0.00 -0.05 -0.052
Sloan Accruals snapshot only 0.084
Cash Flow Adequacy snapshot only 3.198
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.1% -0.2% -0.3% -0.2% -0.1% -11.3% -7.2% -6.0% -5.4% -0.3% -0.3% -0.2% -0.3% -0.4% -1.0% -0.7% -0.3% -0.2% -0.2% -0.4% -0.41%
Total Shareholder Return -0.1% -0.2% -0.3% -0.2% -0.1% -11.3% -7.2% -6.0% -5.4% -0.3% -0.3% -0.2% -0.3% -0.4% -1.0% -0.7% -0.3% -0.2% -0.2% -0.4% -0.41%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.96 0.94 0.87 2.03 1.00 0.99 0.98 0.97 0.99 1.77 1.92 1.925
Interest Burden (EBT/EBIT) 1.15 1.11 1.10 1.09 1.09 1.10 1.11 1.16 1.44 1.28 1.68 6.05 0.16 0.90 0.91 0.88 0.88 0.87 0.89 0.86 0.855
EBIT Margin -0.87 -1.20 -1.33 -1.10 -0.85 -0.54 -0.35 -0.20 -0.08 -0.15 -0.07 -0.01 0.03 0.09 0.09 0.12 0.16 0.19 0.20 0.16 0.164
Asset Turnover 0.23 0.22 0.21 0.27 0.36 0.50 0.45 0.58 0.73 0.93 0.49 0.60 0.73 0.82 0.58 0.65 0.70 0.75 0.65 0.68 0.679
Equity Multiplier 1.62 1.62 1.67 1.67 1.67 1.67 1.61 1.61 1.61 1.61 3.03 3.03 3.03 3.03 4.13 4.13 4.13 4.13 2.67 2.67 2.668
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.09 $-1.37 $-1.59 $-1.68 $-1.71 $-1.40 $-1.13 $-0.88 $-0.55 $-1.10 $-0.73 $-0.29 $0.09 $0.91 $1.01 $1.23 $1.77 $2.25 $4.65 $4.75 $4.75
Book Value/Share $3.76 $3.75 $2.44 $2.43 $2.42 $2.24 $5.85 $5.81 $5.76 $5.75 $4.01 $3.96 $3.89 $3.84 $6.49 $5.73 $5.64 $5.61 $11.56 $13.07 $14.37
Tangible Book/Share $3.76 $3.75 $2.44 $2.43 $2.42 $2.24 $5.85 $5.81 $5.76 $5.75 $3.59 $3.54 $3.48 $3.44 $6.10 $5.38 $5.30 $5.27 $11.23 $12.70 $12.70
Revenue/Share $1.08 $1.02 $1.09 $1.40 $1.84 $2.37 $2.92 $3.69 $4.64 $5.88 $7.07 $8.56 $10.17 $11.24 $12.54 $12.23 $13.10 $13.90 $14.79 $17.57 $18.49
FCF/Share $-0.97 $-1.07 $-1.17 $-1.62 $-1.89 $-2.01 $-1.80 $-1.46 $-1.25 $-4.24 $-4.82 $-5.85 $-5.49 $-3.38 $-2.30 $-1.58 $0.43 $2.96 $3.26 $4.18 $4.40
OCF/Share $-0.96 $-1.06 $-1.04 $-1.43 $-1.55 $-1.60 $-1.43 $-1.12 $-1.01 $-0.78 $-0.38 $-0.22 $0.67 $1.05 $1.39 $1.24 $2.84 $4.37 $4.71 $6.08 $6.40
Cash/Share $4.55 $4.54 $3.33 $3.31 $3.30 $3.06 $6.28 $6.24 $6.18 $6.17 $11.55 $11.38 $11.19 $11.06 $9.56 $8.43 $8.30 $8.26 $11.93 $13.49 $13.43
EBITDA/Share $-0.88 $-1.16 $-1.36 $-1.43 $-1.45 $-1.14 $-0.89 $-0.61 $-0.21 $-0.69 $-0.21 $0.28 $0.67 $1.63 $1.80 $2.07 $2.76 $3.25 $3.63 $3.80 $3.80
Debt/Share $1.25 $1.25 $1.58 $1.57 $1.57 $1.45 $2.11 $2.09 $2.08 $2.07 $15.10 $14.88 $14.62 $14.46 $14.72 $12.99 $12.78 $12.72 $11.48 $12.98 $12.98
Net Debt/Share $-3.29 $-3.28 $-1.75 $-1.74 $-1.74 $-1.61 $-4.17 $-4.14 $-4.11 $-4.10 $3.54 $3.49 $3.43 $3.39 $5.16 $4.55 $4.48 $4.46 $-0.46 $-0.52 $-0.52
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 4.796
Altman Z-Prime snapshot only 9.523
Piotroski F-Score 6 4 3 3 3 2 4 4 5 5 4 4 6 6 7 6 7 7 6 7 7
Beneish M-Score -1.91 -2.88 -3.22 -2.21 -1.85 0.47 0.17 -0.12 -0.07 -0.41 3.41 3.33 3.15 3.03 -2.10 -2.01 -2.28 -2.56 -0.74 -1.03 -1.031
Ohlson O-Score snapshot only -8.494
ROIC (Greenblatt) snapshot only 11.85%
Net-Net WC snapshot only $1.17
EVA snapshot only $136308367.99
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA-
Credit Score 58.73 58.69 32.55 43.47 52.88 59.76 63.38 61.73 62.30 62.23 45.80 36.16 50.87 57.24 48.84 57.39 72.32 79.02 84.07 81.88 81.885
Credit Grade snapshot only 4
Credit Trend snapshot only 24.490
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 75
Sector Credit Rank snapshot only 79

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms